107 related articles for article (PubMed ID: 17161499)
1. Compensation of type I and type II cytokeratin pools in lung cancer.
Kanaji N; Bandoh S; Fujita J; Ishii T; Ishida T; Kubo A
Lung Cancer; 2007 Mar; 55(3):295-302. PubMed ID: 17161499
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratins negatively regulate the invasive potential of lung cancer cell lines.
Kanaji N; Bandoh S; Ishii T; Fujita J; Ishida T; Matsunaga T; Kubo A
Oncol Rep; 2011 Oct; 26(4):763-8. PubMed ID: 21701782
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characterization of cytokeratins in the abnormal corneal endothelium of posterior polymorphous corneal dystrophy patients.
Jirsova K; Merjava S; Martincova R; Gwilliam R; Ebenezer ND; Liskova P; Filipec M
Exp Eye Res; 2007 Apr; 84(4):680-6. PubMed ID: 17289024
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
5. Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell lines.
Fujita J; Dobashi N; Ohtsuki Y; Ueda Y; Bandoh S; Yamadori I; Takahara J
Br J Cancer; 1999 Nov; 81(5):769-73. PubMed ID: 10555744
[TBL] [Abstract][Full Text] [Related]
6. [Cytokeratins as markers of differentiation. Expression profiles in epithelia and epithelial tumors].
Moll R
Veroff Pathol; 1993; 142():1-197. PubMed ID: 7504860
[TBL] [Abstract][Full Text] [Related]
7. Molecular diversity of cytokeratins: significance for cell and tumor differentiation.
Moll R
Acta Histochem Suppl; 1991; 41():117-27. PubMed ID: 1725827
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.
Naka T; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
Mod Pathol; 1997 Jun; 10(6):545-51. PubMed ID: 9195570
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: an immunohistochemical study.
Apaydin R; Gürbüz Y; Bayramgürler D; Bilen N
Amyloid; 2005 Mar; 12(1):41-7. PubMed ID: 16076610
[TBL] [Abstract][Full Text] [Related]
10. Heterotypic interactions and filament assembly of type I and type II cytokeratins in vitro: viscometry and determinations of relative affinities.
Hofmann I; Franke WW
Eur J Cell Biol; 1997 Feb; 72(2):122-32. PubMed ID: 9157008
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
Broers JL; Ramaekers FC; Rot MK; Oostendorp T; Huysmans A; van Muijen GN; Wagenaar SS; Vooijs GP
Cancer Res; 1988 Jun; 48(11):3221-9. PubMed ID: 2452687
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
13. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
15. Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissues from patients with idiopathic pulmonary fibrosis.
Iyonaga K; Miyajima M; Suga M; Saita N; Ando M
J Pathol; 1997 Jun; 182(2):217-24. PubMed ID: 9274534
[TBL] [Abstract][Full Text] [Related]
16. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer.
Chen Y; Cui T; Yang L; Mireskandari M; Knoesel T; Zhang Q; Pacyna-Gengelbach M; Petersen I
Oncology; 2011; 80(5-6):333-40. PubMed ID: 21791943
[TBL] [Abstract][Full Text] [Related]
18. Full-length cytokeratin 8 is released and circulates in patients with non-small cell lung cancer.
Ishii T; Bandoh S; Fujita J; Ohtsuki Y; Tojo Y; Kanaji N; Fukunaga Y; Ueda Y; Ishida T; Kubo A
Tumour Biol; 2008; 29(1):57-62. PubMed ID: 18497550
[TBL] [Abstract][Full Text] [Related]
19. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
20. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
